Villaganas, Agustina .
HRN: 23-03-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2023
CEFUROXIME 500MG (TAB)
06/26/2023
07/02/2023
PO
500mg
BID
S/P RMLE, Elevated WBC
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes